On Monday, ATAI Life Sciences N.V (NASDAQ: ATAI) was -8.39% drop from the session before settling in for the closing price of $5.84. A 52-week range for ATAI has been $1.05 – $6.75.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 18.62%. When this article was written, the company’s average yearly earnings per share was at 46.96%. With a float of $174.80 million, this company’s outstanding shares have now reached $212.24 million.
ATAI Life Sciences N.V (ATAI) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward ATAI Life Sciences N.V stocks. The insider ownership of ATAI Life Sciences N.V is 33.04%, while institutional ownership is 10.43%. The most recent insider transaction that took place on Aug 14 ’25, was worth 19,000,000. In this transaction 10% Owner of this company bought 8,675,799 shares at a rate of $2.19, taking the stock ownership to the 51,045,214 shares. Before that another transaction happened on Jul 02 ’25, when Company’s Officer proposed sale 83,332 for $2.81, making the entire transaction worth $233,830.
ATAI Life Sciences N.V (ATAI) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.16 earnings per share (EPS) during the time that was better than consensus figure (set at -0.16) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.78% during the next five years compared to 18.62% growth over the previous five years of trading.
ATAI Life Sciences N.V (NASDAQ: ATAI) Trading Performance Indicators
You can see what ATAI Life Sciences N.V (ATAI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4232.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of ATAI Life Sciences N.V (ATAI)
The latest stats from [ATAI Life Sciences N.V, ATAI] show that its last 5-days average volume of 5.01 million was superior to 4.33 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 20.61%.
During the past 100 days, ATAI Life Sciences N.V’s (ATAI) raw stochastic average was set at 70.53%, which indicates a significant increase from 4.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.24, while its 200-day Moving Average is $2.96. Now, the first resistance to watch is $5.71. This is followed by the second major resistance level at $6.08. The third major resistance level sits at $6.29. If the price goes on to break the first support level at $5.13, it is likely to go to the next support level at $4.92. The third support level lies at $4.55 if the price breaches the second support level.
ATAI Life Sciences N.V (NASDAQ: ATAI) Key Stats
There are 233,779K outstanding shares of the company, which has a market capitalization of 1.40 billion. As of now, sales total 310 K while income totals -149,270 K. Its latest quarter income was 720 K while its last quarter net income were -27,730 K.
